Brief: Myriad Genetics Q1 EPS USD -0.36
05/05/2026 21:05
May 05 (Reuters) - Myriad Genetics Q1 revenue USD 200.4 million vs. IBES estimate USD 202.5 million. Q1 adjusted operating expenses USD 148.5 million Q1 gross margin 68.7% Q1 net income USD -34.1 million Q1 adjusted EPS USD -0.09 vs. IBES estimate USD -0.07 Q1 operating expenses USD 168.3 million Q1 operating income USD -30.7 million
Recent news on Myriad Genetics
See all newsUS STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
US STOCKS ON THE MOVE-Hilton, MSCI, Tradeweb, Eli Lilly
Myriad jumps after agreeing to sell prenatal health testing business
Brief: Myriad Genetics To Sell Prenatal Health Testing Business To Labcorp
U.S. STOCKS ON THE MOVE- Medtronic, Comstock, Apple